Bio-Rad Laboratories, Inc.
BIO-BFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Bio-Rad Laboratories, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 18 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated May 13, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Gotham Asset Management, LLC | 2026-03-31 | 152,384 | $42.5M | SEC filing |
| CWM, LLC | 2026-03-31 | 387 | $108K | SEC filing |
| TD Asset Management Inc | 2026-03-31 | 9,780 | $2.73M | SEC filing |
| MATHER GROUP, LLC. | 2026-03-31 | 58 | $16.2K | SEC filing |
| STIFEL FINANCIAL CORP | 2026-03-31 | 4,589 | $1.28M | SEC filing |
| JNE Partners LLP | 2026-03-31 | 92,100 | $25.7M | SEC filing |
| Sachetta, LLC | 2026-03-31 | 5 | $1.39K | SEC filing |
| OAKWORTH CAPITAL, INC. | 2026-03-31 | 24 | $6.69K | SEC filing |
| MORGAN STANLEY | 2026-03-31 | 273,931 | $76.4M | SEC filing |
| GHP Investment Advisors, Inc. | 2026-03-31 | 16 | $4.46K | SEC filing |
| STATE STREET CORP | 2026-03-31 | 559,570 | $156M | SEC filing |
| TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | 2026-03-31 | 36,444 | Not shown | SEC filing |
| State of Alaska, Department of Revenue | 2026-03-31 | 1,811 | Not shown | SEC filing |
| Quantedge Capital Pte Ltd | 2026-03-31 | 6,940 | $1.93M | SEC filing |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 2026-03-31 | 226,070 | $63M | SEC filing |
| Boston Trust Walden Corp | 2026-03-31 | 93,495 | $26.1M | SEC filing |
| Portolan Capital Management, LLC | 2026-03-31 | 14,173 | $3.95M | SEC filing |
| Tikvah Management LLC | 2026-03-31 | 97,834 | $27.3M | SEC filing |
| ROWLANDMILLER & PARTNERS.ADV | 2026-03-31 | 565 | $157K | SEC filing |
| SJS Investment Consulting Inc. | 2026-03-31 | 3 | $837 | SEC filing |
- Each value is checked against Bio-Rad Laboratories, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 2 rows: the filed value is about 1,000 times too small for the share count at Bio-Rad Laboratories, Inc.'s share price.
120 filers have only one report here.
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-05-11 | ENGELHARDT EVA ANETTE · EVP, President, CDG | Bio-Rad A Common Stock | S — Open market or private sale | −550 | 246.54 | SEC filing |
| 2025-11-06 | BARRY JAMES · EVP, President, LSG | Bio-Rad A Common Stock | S — Open market or private sale | −700 | 306.18 | SEC filing |
| 2025-03-14 | Crowley Michael · EVP, GBL Commercial Operations | Bio-Rad A Common Stock | S — Open market or private sale | −3,000 | 247.06 | SEC filing |
| 2024-09-06 | Last Andrew J. · EVP, Chief Operating Officer | Bio-Rad A Common Stock | S — Open market or private sale | −3,000 | 329.94 | SEC filing |
| 2024-09-04 | BARRY JAMES · EVP, President, LSG | Bio-Rad A Common Stock | S — Open market or private sale | −623 | 330.49 | SEC filing |
| 2024-06-13 | Crowley Michael · EVP, GBL Commercial Operations | Bio-Rad A Common Stock | S — Open market or private sale | −369 | 281.91 | SEC filing |
| 2024-02-28 | ERNST TIMOTHY S · EVP, General Counsel & Sec | Bio-Rad A Common Stock | S — Open market or private sale | −2,500 | 330.55 | SEC filing |
| 2024-02-27 | Crowley Michael · EVP, GBL Commercial Operations | Bio-Rad A Common Stock | S — Open market or private sale | −3,000 | 336.00 | SEC filing |
Showing 8 of 9 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-04-24 | ENLOE COURTNEY C · EVP, General Counsel & Sec | Restricted Stock Units | M — Exercise or conversion of derivative security | −186 | SEC filing |
| 2026-04-24 | ENLOE COURTNEY C · EVP, General Counsel & Sec | Bio-Rad A Common Stock | M — Exercise or conversion of derivative security | +186 | SEC filing |
| 2026-04-24 | Lakkaraju Roop Kalyan · EVP, Chief Financial Officer | Bio-Rad A Common Stock | M — Exercise or conversion of derivative security | +1,078 | SEC filing |
| 2026-04-24 | Lakkaraju Roop Kalyan · EVP, Chief Financial Officer | Restricted Stock Units | M — Exercise or conversion of derivative security | −1,078 | SEC filing |
| 2026-04-24 | Lakkaraju Roop Kalyan · EVP, Chief Financial Officer | Bio-Rad A Common Stock | F — Payment of exercise price or tax by delivering securities | −420 | SEC filing |
| 2026-04-24 | ENLOE COURTNEY C · EVP, General Counsel & Sec | Bio-Rad A Common Stock | F — Payment of exercise price or tax by delivering securities | −77 | SEC filing |
| 2026-04-21 | PINKSTON ARNOLD A · Director | Bio-Rad A Common Stock | M — Exercise or conversion of derivative security | +407 | SEC filing |
| 2026-04-21 | EDWARDS JEFFREY L · Director | Bio-Rad A Common Stock | M — Exercise or conversion of derivative security | +407 | SEC filing |
Showing 8 of 37 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.